Search

Enzyme USP15 May Have Potential Role in Future Treatment of Various Cancers
A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.
GW Cancer Center Presents at American Academy of Dermatology Annual Meeting
The George Washington University (GW) Cancer Center and the GW School of Medicine and Health Sciences (SMHS) will have a large presence at the upcoming American Academy of Dermatology Association (AAD) Annual Meeting. The meeting will be held at the Walter E. Washington Convention Center in…
GW Cancer Center Approved for $300,000 Engagement Award for Project on Cancer Survivorship Care Quality
A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
Q&A: Anne-Laure Papa, PhD Discusses Research at the Intersection of Engineering, Biology and Medicine
Dr. Papa is an expert in engineering novel therapeutic platforms at the intersection of chemistry, biology and medicine. Her work in the School of Engineering and Applied Science focuses on disease processes, particularly in cancer and vascular diseases, with the goal of designing targeted…
Researchers Develop Reversible, Drug-Free Antiplatelet Therapy to Fight Dangerous Blood Clots and Cancer Metastasis
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.
News from the Breast Cancer Disparities Work Group
The GW Cancer Center hosts a monthly breast cancer disparities work group to facilitate connections across the University between researchers, clinicians and members of the community, including survivors and caregivers.
GW Cancer Researchers Investigate Nanoimmunotherapies for Cancer
WASHINGTON (Jan. 28, 2018) - A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.
GW Cancer Center Publications Highlight Importance of Patient Navigation and Cancer Survivorship
Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in patient…
Q&A: Tommy Ballard Discusses Clinical Operations at the GW Cancer Center
Tommy Ballard has been with GW since 2013 and manages the operational and administrative functions for the GW Cancer Center's clinical programs. What brought you to GW?
Vishal A. Patel, MD Joins GW Cancer Center to Lead Multi-disciplinary Cutaneous Oncology Program
The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program…